Literature DB >> 11776011

Vaginal microbicides for HIV/STI prevention in Zimbabwe: what key informants say.

Martha W Moon1, Gertrude N Khumalo-Sakutukwa, Judith E Heiman, Michael T Mbizvo, Nancy S Padian.   

Abstract

The purpose of this study was to assess the acceptability of vaginal microbicides as prevention methods for heterosexually transmitted HIV. Interviews were conducted with key informants in and around Harare using a semistructured questionnaire with probes. Twenty-seven interviews were conducted with a total of 48 informants. Most women were enthusiastic about the products but had concerns about safety and how the use of these products might affect their relationships with their husbands. Many men were concerned that women would be able to use the products without their consent or knowledge. Several products may be acceptable in this culture but must be introduced within the existing gender power structure. This study provides a model for involving community leaders in the design of culturally appropriate clinical trials.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11776011     DOI: 10.1177/104365960201300104

Source DB:  PubMed          Journal:  J Transcult Nurs        ISSN: 1043-6596            Impact factor:   1.959


  6 in total

1.  Attitudes towards microbicide use for bacterial vaginosis in pregnancy.

Authors:  Marina Catallozzi; Camille Y Williams; Gregory D Zimet; Katharine M Hargreaves; Shari E Gelber; Adam J Ratner; Lawrence R Stanberry; Susan L Rosenthal
Journal:  Sex Health       Date:  2014-09       Impact factor: 2.706

2.  Vaginal microbicide and diaphragm use for sexually transmitted infection prevention: a randomized acceptability and feasibility study among high-risk women in Madagascar.

Authors:  Frieda M Behets; Abigail Norris Turner; Kathleen Van Damme; Ny Lovaniaina Rabenja; Noro Ravelomanana; Teresa A Swezey; April J Bell; Daniel R Newman; D'Nyce L Williams; Denise J Jamieson
Journal:  Sex Transm Dis       Date:  2008-09       Impact factor: 2.830

3.  Acceptability of a microbicide among women and their partners in a 4-country phase I trial.

Authors:  Margaret E Bentley; Andrew M Fullem; Elizabeth E Tolley; Clifton W Kelly; Neelam Jogelkar; Namtip Srirak; Liness Mwafulirwa; Gertrude Khumalo-Sakutukwa; David D Celentano
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

4.  The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe.

Authors:  Elizabeth T Montgomery; Ariane van der Straten; Agnes Chidanyika; Tsungai Chipato; Shabbar Jaffar; Nancy Padian
Journal:  AIDS Behav       Date:  2011-07

5.  Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa.

Authors:  Elizabeth T Montgomery; Helen Cheng; Ariane van der Straten; Agnes C Chidanyika; Naomi Lince; Kelly Blanchard; Gita Ramjee; Busisiwe Nkala; Nancy S Padian
Journal:  AIDS Behav       Date:  2009-09-10

Review 6.  Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.

Authors:  Adamson S Muula; Thabale J Ngulube; Seter Siziya; Cecilia M Makupe; Eric Umar; Hans Walter Prozesky; Charles S Wiysonge; Ronald H Mataya
Journal:  BMC Public Health       Date:  2007-04-25       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.